Method D Segeja

Summary

Publications

  1. ncbi Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania
    Method D Segeja
    National Institute for Medical Research, Tanga Medical Research Centre, Tanga, Tanzania
    BMC Infect Dis 10:55. 2010
  2. ncbi Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania
    Bruno P Mmbando
    National Institute for Medical Research, Tanga Medical Research Centre, Tanga, Tanzania
    Malar J 8:165. 2009
  3. ncbi Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months
    John P A Lusingu
    National Institute for Medical Research, Tanga Centre, Tanzania
    Malar J 8:163. 2009
  4. ncbi High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania
    Martha Lemnge
    National Institute for Medical Research, Tanga Centre, Tanga, Tanzania
    Am J Trop Med Hyg 75:188-93. 2006

Collaborators

Detail Information

Publications4

  1. ncbi Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania
    Method D Segeja
    National Institute for Medical Research, Tanga Medical Research Centre, Tanga, Tanzania
    BMC Infect Dis 10:55. 2010
    ..This study aimed at assessing natural acquisition of antibodies to MSP3 in individuals living in an area with different malaria transmission intensity in preparation for malaria vaccine trials...
  2. ncbi Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania
    Bruno P Mmbando
    National Institute for Medical Research, Tanga Medical Research Centre, Tanga, Tanzania
    Malar J 8:165. 2009
    ..Four villages had passive case detection (PCD) of fever system using village health workers...
  3. ncbi Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months
    John P A Lusingu
    National Institute for Medical Research, Tanga Centre, Tanzania
    Malar J 8:163. 2009
    ..A phase Ib dose-escalating study was conducted to assess the vaccine's safety and immunogenicity in children aged 12 to 24 months in Korogwe, Tanzania (ClinicalTrials.gov number: NCT00469651)...
  4. ncbi High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania
    Martha Lemnge
    National Institute for Medical Research, Tanga Centre, Tanga, Tanzania
    Am J Trop Med Hyg 75:188-93. 2006
    ..6% (9/26) in the above settings, respectively. Frequency of Pfcrt CVIET haplotype mutation pretreatment was high (97.0%); the remaining samples were CVMNK. We conclude that AQ alone is no longer effective in the study area...